Cargando…

Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time

OBJECTIVE: To determine the long‐term impact of prior SARS‐CoV‐2 infection on immune responses after COVID‐19 vaccination. METHODS: Using longitudinally collected blood samples from the COMMUNITY study, we determined binding (WHO BAU mL(−1)) and neutralising antibody titres against ten SARS‐CoV‐2 va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Havervall, Sebastian, Marking, Ulrika, Greilert‐Norin, Nina, Gordon, Max, Ng, Henry, Christ, Wanda, Phillipson, Mia, Nilsson, Peter, Hober, Sophia, Blom, Kim, Klingström, Jonas, Mangsbo, Sara, Åberg, Mikael, Thålin, Charlotte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015077/ https://www.ncbi.nlm.nih.gov/pubmed/35444806 http://dx.doi.org/10.1002/cti2.1388

Ejemplares similares

Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
por: Marking, Ulrika, et al.
Publicado: (2022)

Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection
por: Blom, Kim, et al.
Publicado: (2022)

Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers
por: Marking, Ulrika, et al.
Publicado: (2023)

Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
por: Havervall, Sebastian, et al.
Publicado: (2021)

Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose
por: Bladh, Oscar, et al.
Publicado: (2023)

Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
por: Havervall, Sebastian, et al.
Publicado: (2022)

Point prevalence of SARS-CoV-2 infection among healthcare workers in March and June 2023 in Sweden
por: Blom, Kim, et al.
Publicado: (2023)

Infection Rate of SARS-CoV-2 in Asymptomatic Healthcare Workers, Sweden, June 2022
por: Blom, Kim, et al.
Publicado: (2022)

7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection
por: Marking, Ulrika, et al.
Publicado: (2023)

An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses
por: Mangsbo, Sara M., et al.
Publicado: (2021)

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19
por: Havervall, Sebastian, et al.
Publicado: (2021)

SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
por: Havervall, Sebastian, et al.
Publicado: (2022)

Long‐term SARS‐CoV‐2‐specific and cross‐reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology
por: Laurén, Ida, et al.
Publicado: (2022)

A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies
por: Mravinacova, Sara, et al.
Publicado: (2022)

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
por: Rudberg, Ann-Sofie, et al.
Publicado: (2020)

IL-6 signalling biomarkers in hospitalised patients with moderate to severe SARS-CoV-2 infection in a single centre study in Sweden
por: Ziegler, Louise, et al.
Publicado: (2022)

Impact of monocyte‐related modulators and kidney function on mortality in hospitalized patients with COVID‐19
por: Sendic, Senka, et al.
Publicado: (2022)

“Role of kidney function and concentrations of BAFF, sPD-L1 and sCD25 on mortality in hospitalized patients with COVID-19”
por: Mansouri, Ladan, et al.
Publicado: (2022)

Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma
por: Zenlander, Robin, et al.
Publicado: (2021)

Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer
por: Thålin, Charlotte, et al.
Publicado: (2018)

Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational study
por: Vikström, Linnea, et al.
Publicado: (2023)

Elevated factor V activity and antigen levels in patients with Covid‐19 are related to disease severity and 30‐day mortality
por: von Meijenfeldt, Fien A., et al.
Publicado: (2021)

Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge
por: von Meijenfeldt, Fien A., et al.
Publicado: (2021)

Soluble angiotensin‐converting enzyme 2 is transiently elevated in COVID‐19 and correlates with specific inflammatory and endothelial markers
por: Lundström, Annika, et al.
Publicado: (2021)

Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality
por: von Meijenfeldt, Fien A., et al.
Publicado: (2020)

Molecular Diagnosis of Hemorrhagic Fever with Renal Syndrome Caused by Puumala Virus
por: Lagerqvist, Nina, et al.
Publicado: (2016)

Female Mice are Protected against High-Fat Diet Induced Metabolic Syndrome and Increase the Regulatory T Cell Population in Adipose Tissue
por: Pettersson, Ulrika S., et al.
Publicado: (2012)

Clinical grade ACE2 as a universal agent to block SARS‐CoV‐2 variants
por: Monteil, Vanessa, et al.
Publicado: (2022)

Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron Variant
por: Lindahl, Hannes, et al.
Publicado: (2022)

Increased Recruitment but Impaired Function of Leukocytes during Inflammation in Mouse Models of Type 1 and Type 2 Diabetes
por: Pettersson, Ulrika Sofia, et al.
Publicado: (2011)

The neutrophil: one cell on many missions or many cells with different agendas?
por: Christoffersson, Gustaf, et al.
Publicado: (2018)

The neutrophil in vascular inflammation
por: Phillipson, Mia, et al.
Publicado: (2011)

Identification of Clec4b as a novel regulator of bystander activation of auto-reactive T cells and autoimmune disease
por: Bäckdahl, Liselotte, et al.
Publicado: (2020)

Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination
por: Normark, Johan, et al.
Publicado: (2021)

Tissue factor activity of small and large extracellular vesicles in different diseases
por: Sachetto, Ana T.A., et al.
Publicado: (2023)

Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses
por: Glans, Hedvig, et al.
Publicado: (2021)

Comprehensive proteomics and meta-analysis of COVID-19 host response
por: Babačić, Haris, et al.
Publicado: (2023)

Sensitivity of Andes Hantavirus to Antiviral Effect of Human Saliva
por: Hardestam, Jonas, et al.
Publicado: (2009)

Dobrava, but not Saaremaa, hantavirus is lethal and induces nitric oxide production in suckling mice
por: Klingström, Jonas, et al.
Publicado: (2006)

Engineering of Bispecific Affinity Proteins with High Affinity for ERBB2 and Adaptable Binding to Albumin
por: Nilvebrant, Johan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mdj7fr4dnlvehuabvn8hl1pugb